Evaluating adverse drug reactions among HAART patients in a resource-constrained province of South Africa

References

• Boulle , A. , Orrell , C. , Kaplan , R. , Van Cutsem , G. , McNally , M. , Hilderbrand , K. , Myer , L. , Egger , M. , Coetzee , D. , Maartens , G. and Wood , R. 2007 . Substitutions due to antiretroviral toxicity or contraindication in the first three years of antiretroviral therapy in a large South African cohort . Antiviral Therapy , 12 ( 5 ) : 753 – 760 .
   PubMed Web of Science ®Google Scholar
• Department of Health [South Africa] 2001 National HIV and Syphilis Sero-Prevalence Survey of Women Attending Public Antenatal Clinics in South Africa . National Department of Health , Pretoria , , South Africa .
   Google Scholar
• Department of Health [South Africa] 2003 Operational Plan for Comprehensive HIV and AIDS Care, Management and Treatment for South Africa . Pretoria , , South Africa , National Department of Health .
   Google Scholar
• Department of Health [South Africa] 2004 National Antiretroviral Treatment Guidelines . Pretoria , , South Africa , National Department of Health .
   Google Scholar
• Department of Health [South Africa] 2010 National Antenatal Sentinel HIV and Syphilis Prevalence Survey in South Africa . Pretoria , , South Africa , National Department of Health .
   Google Scholar
• Dragovic , G. and Jevtovic , D. 2003 . Nucleoside reverse transcriptase inhibitor usage and the incidence of peripheral neuropathy in HIV/AIDS patients . Antiviral Chemistry and Chemotherapy , 14 ( 5 ) : 281 – 284 .
   PubMedGoogle Scholar
• Geddes , R. , Knight , S. , Moosa , M.Y. , Reddi , A. , Uebel , K. and Sunpath , H. 2006 . A high incidence of nucleoside reverse transcriptase inhibitor (NRTI)-induced lactic acidosis in HIV-infected patients in a South African context . South African Medical Journal , 96 ( 8 ) : 722 – 724 .
   PubMed Web of Science ®Google Scholar
• Harris , R.Z. , Benet , L.Z. and Schwartz , J.B. 1995 . Gender effects in pharmacokinetics and pharmacodynamics . Drugs , 50 ( 2 ) : 222 – 239 .
   PubMed Web of Science ®Google Scholar
• Lonergan , J. , McComsey , G. , Fisher , R. , Shalit , P. , File , T. , Ward , D. , Williams , V. , Hessenthaler , S. , Lindsey , L. and Hernandez , J. 2004 . Lack of recurrence of hyperlactatemia in HIV-infected patients switched from stavudine to abacavir or zidovudine . Journal of Acquired Immune Deficiency Syndromes , 36 ( 4 ) : 935 – 942 .
   PubMed Web of Science ®Google Scholar
• Mbangwa , L 2007 ‘ KwaZulu-Natal Province leads the way in HIV and AIDS treatment .’ KwaZulu-Natal Department of Health, Corporate Communications , 13 August , 2007 Durban , , South Africa .
   Google Scholar
• McComsey , G.A. and Leonard , E. 2004 . Metabolic complications of HIV therapy in children . AIDS , 18 ( 13 ) : 1753 – 1768 .
   PubMed Web of Science ®Google Scholar
• McComsey , G. , Paulsen , D. , Lonergan , J. , Hessenthaler , S. , Hoppel , C. , Williams , V. , Fisher , R. , Cherry , C. , White-Owen , C. , Thompson , K. , Ross , S. , Hernandez , J. and Ross , L. 2005 . Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine . AIDS , 19 ( 1 ) : 15 – 23 .
   PubMed Web of Science ®Google Scholar
• McDowell , S.E. , Coleman , J.J. and Ferner , R.E. 2006 . Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine . British Medical Journal , 332 ( 7551 ) : 1177 – 1181 .
   PubMed Web of Science ®Google Scholar
• Nolan , D. and Mallal , S. 2003 . Thymidine analogue-sparing highly active antiretroviral therapy (HAART) . Journal of HIV Therapy , 8 ( 1 ) : 2 – 6 .
   PubMedGoogle Scholar
• Reddi , A. , Leeper , S. , Grobler , A. , Geddes , R. , France , K.H. , Dorse , G. , Vlok , W. , Mntambo , M. , Thomas , M. , Nixon , K. , Holst , H. , Karim , Q. , Rollins , N. , Coovadia , H. and Giddy , J. 2007 . Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa . BMC Pediatrics , 7 ( 1 ) : 1 – 13 .
   PubMedGoogle Scholar
• Shisana , O , Rehle , T , Simbayi , L , Parker , W , Zuma , K , Bhana , A , Connolly , C , Jooste , S & Pillay , V 2005 South African National HIV Prevalence, HIV Incidence, Behaviour and Communication Survey, 2005 . Cape Town , , South Africa , HSRC Press .
   Google Scholar
• Tran , C. , Knowles , S.R. , Liu , B.A. and Shear , N.H. 1998 . Gender differences in adverse drug reactions . Journal of Clinical Pharmacology , 38 ( 11 ) : 1003 – 1009 .
   PubMed Web of Science ®Google Scholar
• Westreich , D.J. , Sanne , I. , Maskew , M. , Malope-Kgokong , B. , Conradie , F. , Majuba , P. , Funk , M.J. , Kaufman , J.S. , Van Rie , A. and MacPhail , P. 2009 . Tuberculosis treatment and risk of stavudine substitution in first-line antiretroviral therapy . Clinical Infectious Diseases , 48 ( 11 ) : 1617 – 1623 .
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO) 2004 Pharmacovigilance: Ensuring the Safe Use of Medicines . WHO , Geneva .
   Google Scholar
• World Health Organization (WHO) 2007 Pharmacovigilance for Antiretrovirals in Resource-Poor Countries . April 2007, WHO/ PSM/QSM/2007.3 . WHO , Geneva .
   Google Scholar